Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis methodsPharmacoeconomics Jun 9 Written By Matthijs Versteegh multiple sclerosis Matthijs Versteegh
Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis methodsPharmacoeconomics Jun 9 Written By Matthijs Versteegh multiple sclerosis Matthijs Versteegh
